Related Experiment Video

Updated: Jun 16, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus

Alfonso Iorio1, Emanuela Marchesini, Tahany Awad

  • 1Department of Internal Medicine, University of Perugia, Ospedale Santa Maria della Misericordia, Località Sant'Andrea delle Fratte, Perugia, Italy, 06126.

The Cochrane Database of Systematic Reviews
|January 22, 2010
PubMed

Insights

Peginterferon plus ribavirin effectively treats chronic hepatitis C in patients with HIV, clearing HCV RNA. However, careful monitoring for adverse events like anemia and flu-like symptoms is crucial.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Co-infection with human immunodeficiency virus (HIV) can reduce the effectiveness of antiviral treatment for chronic hepatitis C.
  • Assessing treatment efficacy and safety in this specific patient population is critical.

Purpose of the Study:

  • To evaluate the benefits and harms of antiviral therapies for chronic hepatitis C in individuals coinfected with HIV.
  • To determine optimal treatment strategies for hepatitis C in the context of HIV coinfection.

Main Methods:

  • Systematic review of randomized controlled trials comparing anti-hepatitis C virus (HCV) treatments.
  • Included patients had chronic hepatitis C and stable HIV, regardless of prior treatment.
  • Data extraction and risk of bias assessment were performed in duplicate; intention-to-treat analysis was used.

Main Results:

  • Peginterferon plus ribavirin demonstrated higher efficacy in achieving end-of-treatment and sustained virological response compared to interferon plus ribavirin or peginterferon alone.
  • Treatment benefits were observed across HCV genotypes, though response rates were lower for genotypes 1 and 4.
  • Overall mortality showed no significant difference between treatment regimens, but adverse events such as anemia and flu-like symptoms increased, with rare serious events reported.

Conclusions:

  • Peginterferon plus ribavirin is a potential treatment for treatment-naive patients with chronic hepatitis C and stable HIV, showing promise in clearing HCV RNA.
  • Evidence primarily supports its use based on surrogate outcomes; data for patients with prior treatment failure are lacking.
  • Close monitoring for adverse events is essential due to increased risks associated with the treatment.
Abstract

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...